(firstQuint)A Pilot Trial of Triheptanoin for the Preventive Treatment of Migraine.

 To test the ability of a daily 3-month treatment with triheptanoin to prevent migraine attacks in 10 migraine patients.

 This is an open, non-randomized pilot trial that might justify a placebo-controlled trial, if there are at least 50% of patients with 50% reduction in attack frequency.

.

 A Pilot Trial of Triheptanoin for the Preventive Treatment of Migraine@highlight

A pilot trial of triheptanoin, a natural compound able to promote anaplerotic mitochondrial metabolism, for the preventative treatment of migraine.

